Safety and Immunogenicity of an mRNA-1273 Booster in Children
2024

Safety and Immunogenicity of an mRNA-1273 Booster in Children

Sample size: 2672 publication 10 minutes Evidence: high

Author Information

Author(s): Berthaud Vladimir, Creech C Buddy, Rostad Christina A, Carr Quito, de Leon Liberation, Dietrich Monika, Gupta Anil, Javita David, Nachman Sharon, Pinninti Swetha, Rathore Mobeen, Rodriguez Carina A, Luzuriaga Katherine, Towner William, Yeakey Anne, Brown Mollie, Zhao Xiaoping, Deng Weiping, Xu Wenqin, Zhou Honghong, Girard Bethany, Kelly Roxanne, Slobod Karen, Anderson Evan J, Das Rituparna, Miller Jacqueline, Schnyder Ghamloush Sabine

Primary Institution: Moderna, Inc

Hypothesis

Does an mRNA-1273 booster dose improve immune response in children aged 6 months to 11 years?

Conclusion

The mRNA-1273 booster dose is safe and elicits strong immune responses in children aged 6 months to 11 years.

Supporting Evidence

  • The booster dose safety profile was consistent with the primary series.
  • Robust neutralizing antibody responses were observed post-booster.
  • Noninferiority criteria were met for immune responses compared to young adults.
  • Adverse events were mostly mild to moderate.
  • No new safety concerns were identified.

Takeaway

Giving a booster shot of the mRNA-1273 vaccine to kids helps their bodies fight off COVID-19 better.

Methodology

Participants received an mRNA-1273 booster dose 6 months after the primary series, and their immune responses were measured.

Potential Biases

Potential conflicts of interest due to authors' affiliations with Moderna, Inc.

Limitations

The study had a limited sample size and may not detect rare safety events.

Participant Demographics

Participants included 153 children aged 6 months to 5 years and 2519 children aged 6 to 11 years, with a majority being White.

Statistical Information

P-Value

3.9

Confidence Interval

95% CI: 3.2–4.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/cid/ciae420

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication